Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Sample Size Calculation
100%
Sample Size Formula
69%
Older Persons
68%
Coronary Artery Disease
66%
Risk Ratio
58%
Phase II Trial
58%
Risk Factors
55%
Coronary Events
54%
Repeated Measurements
51%
Generalized Estimating Equations
49%
Elderly Patients
49%
United States
45%
Congestive Heart Failure
44%
95% Confidence Interval
44%
Simulation Study
44%
Stereotactic Ablative Radiotherapy
42%
Odds Ratio
41%
Systemic Sclerosis
40%
Peripheral Arterial Disease
38%
Overall Survival
37%
Tumor
37%
Older Women
36%
Atherothrombotic Brain Infarction
36%
Older Men
36%
Colonoscopy
34%
Clinical Trials
33%
Hypertension
33%
Prior Myocardial Infarction
31%
Missing Data
31%
Binary Outcome
31%
Maximum Tolerated Dose
31%
Statins
31%
Systemic Lupus Erythematosus
31%
Older Patients
30%
Independent Risk Factors
30%
Cluster Size
30%
Colorectal Cancer
29%
Randomized Clinical Trial
29%
Non-small Cell Lung Cancer (NSCLC)
27%
African American
27%
Carotid Arterial Disease
26%
Heart Disease
26%
Rate of Change
26%
Correlation Structure
26%
Breast Cancer
25%
Hazard Ratio
25%
Safety-net Hospital
25%
Left Ventricular Ejection Fraction
25%
Colorectal Cancer Screening
25%
Diabetes Mellitus
25%
Medicine and Dentistry
Radiation Therapy
87%
Diseases
58%
Breast Cancer
51%
Overall Survival
47%
Prevalence
46%
Neoplasm
43%
Colorectal Carcinoma
41%
Colonoscopy
40%
Malignant Neoplasm
40%
Non Small Cell Lung Cancer
37%
Clinical Trial
33%
Recurrent Disease
31%
Coronary Artery Disease
31%
Chemotherapy
31%
Odds Ratio
30%
Hypertension
29%
Elderly Patient
28%
Congestive Heart Failure
25%
Myocardial Infarction
24%
Hazard Ratio
24%
Primary Health Care
23%
Phase II Trials
23%
Logistic Regression Analysis
22%
Colorectal Cancer Screening
22%
Health System
21%
Proportional Hazards Model
20%
Prostate Cancer
19%
Neck
19%
Arm
19%
Statin
19%
Apoplexy
18%
Progression Free Survival
18%
Left Ventricular Hypertrophy
18%
Drug Megadose
17%
Median Follow Up
17%
Brain Infarction
17%
Randomized Clinical Trials
16%
Arteriosclerosis Obliterans
16%
Artery Disease
16%
Partial Breast Irradiation
16%
Dentin
16%
Lupus Nephritis
16%
Atrial Fibrillation
16%
Lymph Node
16%
Prospective Study
15%
Systemic Lupus Erythematosus
15%
Diabetes Mellitus
15%
Prognostic Factor
15%
Faintness
14%
Regression Analysis
14%